No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Shares in German chemicals maker Bayer surged on Friday after a US appeals court said it was protected under federal law which would limit liability from claims that its Roundup weed killer causes cancer.
The case was brought by David Schaffner, a Pennsylvania landscaper diagnosed with non-Hodgkins lymphoma in 2006, who claimed the Bayer had failed to provide a cancer warning on the label of Roundup.
However, the US Circuit Court of Appeals in Philadelphia ruled that the Federal Insecticide, Fungicide, and Rodenticide Act required nationwide uniformity in pesticide labels, and stopped Pennsylvania from adding a cancer warning.
Bayer settled a large portion of the Roundup litigation for $11bn in 2020, but still faces around 58,000 unresolved claims.
Reporting by Frank Prenesti for Sharecast.com
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.